Early phase drug development consulting firm ClinPharm Consulting and 23-year pharmaceutical industry veteran Bill Wargin, Ph.D. have announced a strategic partnership to further enhance ClinPharm Consulting's clinical pharmacology expertise.
Formerly with Burroughs-Wellcome and then GlaxoWellcome, Dr. Wargin has spent the last eight years consulting with numerous clients in all aspects of pre-clinical and clinical pharmacokinetics including study design, data analysis, and strategic planning.
"We're thrilled to be working with a professional like Dr. Wargin and this strategic partnership enhances our efforts to be the premier consulting firm focused exclusively on clinical pharmacology" said Geoffrey Banks, Ph.D., ClinPharm Consulting president. "Bill is well-respected in pharmaceutical and biotechnology circles for his expertise in pharmacokinetics and biopharmaceutics, two key areas of focus for our firm," he added.
Under this partnership, Dr. Wargin will make his breadth of experience available to ClinPharm Consulting's expanding client base of small, emerging pharmaceutical and biotechnology companies that have minimal R&D infrastructure and need assistance with early phase human trials.
"I've known Geoff Banks for many years and have worked with him on numerous projects," Dr. Wargin said, adding, "I have a lot of respect for what he's doing with ClinPharm Consulting and look forward to helping our clients with their development programs."
ClinPharm Consulting is able to offer a full clinical pharmacology development package to clients and be a complete resource for virtual companies seeking to advance early phase drug development programs.
For more information on ClinPharm Consulting, contact Dr. Geoffrey Banks at email@example.com or visit www.clinpharmworld.com
About ClinPharm Consulting
ClinPharm Consulting, LLC is a specialized consulting firm focused on clinical pharmacology and is uniquely positioned to offer a full range of early phase drug development services and solutions to the industry. Our business model centers on providing cost-effective expertise to small, emerging pharmaceutical and biotechnology companies that have minimal R&D infrastructure. We work as a fully integrated resource for clients needing in-house assistance across their early phase development program, including PK/PD, strategic planning, clinical operations, regulatory, medical writing, project management, etc. This allows ClinPharm Consulting to be a complete resource for virtual companies, thereby reducing costs through increased efficiencies in the drug development process. ClinPharm Consulting can engage clients as early as the IND planning stages to develop robust clinical pharmacology strategies and then assist with the execution and analysis of those strategies, including efforts to transition from nonclinical research into early phase clinical trials as well as transitioning from healthy volunteers into patients with the target disease.